(VGVF) Vanguard FTSE Developed - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BK5BQV03
VGVF: Large-Cap, Global, Equity, Securities, Developed Markets
Vanguard FTSE Developed Developed World UCITS ETF USD Accumulation is a global equity ETF listed on XETRA, providing diversified exposure to large-cap stocks across developed markets. The fund tracks the Morningstar Global TME NR USD index, which comprises a broad representation of the global equity market.
With Assets Under Management (AUM) of approximately €4.96 billion, this ETF is a significant player in the global ETF market. Its Global Large-Cap Blend Equity category positioning indicates a balanced investment approach, neither heavily tilted towards value nor growth. The funds structure and management are designed to offer a cost-effective way to access a wide range of international equities.
Analyzing the ETFs recent price action, we observe a steady uptrend, supported by its 20-day Simple Moving Average (102.15) and and 50-day SMA (98.02), both of which are below the current price of 103..00, indicating a positive short-term momentum. However, the 200-day SMA at 102..37 suggests a slightly more cautious long-term outlook, as the price is marginally above this average. The Average True Range (ATR) of 1.25, or 1..21% of the current price, indicates moderate volatility.
Given the current technical setup and fundamental data, a forecast for VGVF could involve a potential short-term consolidation or slight pullback, given the proximity to the 52-week high of 1111.00. However, if the global equity markets continue their upward trend, supported by positive economic indicators, VGVF is likely to follow, potentially challenging its 52-week high. Conversely, a downturn in global markets could lead to a retracement towards the 52-week low of 87..50. A key driver for VGVFs performance will be the overall direction of the global economy and equity markets.For investors, VGVF offers a diversified portfolio with exposure to a broad range of developed market equities. The funds low-cost structure, courtesy of Vanguards management, enhances its appeal for long-term investors seeking to minimize expenses. As with any investment investment, its essential.00 to monitor the funds tracking efficiency and overall market conditions to adjust investment decisions accordingly.Additional Sources for VGVF ETF
VGVF ETF Overview
Market Cap in USD | 5,798m |
Category | Global Large-Cap Blend Equity |
TER | 0.12% |
IPO / Inception | 2019-09-24 |
VGVF ETF Ratings
Growth Rating | 67.9 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -8.86 |
Analysts | - |
Fair Price Momentum | 98.48 EUR |
Fair Price DCF | - |
VGVF Dividends
Currently no dividends paidVGVF Growth Ratios
Growth Correlation 3m | 65.4% |
Growth Correlation 12m | 31.8% |
Growth Correlation 5y | 90% |
CAGR 5y | 13.33% |
CAGR/Max DD 5y | 0.63 |
Sharpe Ratio 12m | 0.61 |
Alpha | -6.28 |
Beta | 0.752 |
Volatility | 10.21% |
Current Volume | 8k |
Average Volume 20d | 6.8k |
As of June 27, 2025, the stock is trading at EUR 102.06 with a total of 8,005 shares traded.
Over the past week, the price has changed by +0.71%, over one month by -0.08%, over three months by -0.66% and over the past year by +5.14%.
Yes. Based on ValueRay´s Analyses, Vanguard FTSE Developed (XETRA:VGVF) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.93 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VGVF is around 98.48 EUR . This means that VGVF is currently overvalued and has a potential downside of -3.51%.
Vanguard FTSE Developed has no consensus analysts rating.
According to our own proprietary Forecast Model, VGVF Vanguard FTSE Developed will be worth about 112.3 in June 2026. The stock is currently trading at 102.06. This means that the stock has a potential upside of +10.04%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 112.3 | 10% |